Label: DYE-FREE CHILDRENS LORATADINE- loratadine tablet, chewable

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated June 2, 2022

If you are a consumer or patient please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • Active ingredient (in each tablet)

    Loratadine USP, 5 mg

  • Purpose

    Antihistamine

  • Uses

    temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

    •
    runny nose
    •
    sneezing
    •
    itchy, watery eyes
    •
    itching of the nose or throat
  • Warnings

    Do not use if you have ever had an allergic reaction to this product or any of its ingredients.

    Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.

    When using this product do not take more than directed. Taking more than directed may cause drowsiness.

    Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

    If pregnant or breast-feeding, ask a health professional before use.

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

  • Directions

    •
    chew or crush tablets completely before swallowing.

    adults and children 6 years and over

    chew 2 tablets daily; not more than 2 tablets in 24 hours

    children 2 to under 6 years of age

    chew 1 tablet daily; not more than 1 tablet in 24 hours

    children under 2 years of age

    ask a doctor

    consumers with liver or kidney disease

    ask a doctor
  • Other information

    •
    phenylketonurics: contains phenylalanine 1.25 mg per tablet.
    •
    TAMPER EVIDENT: DO NOT USE IF BLISTER UNITS ARE TORN, BROKEN OR SHOW ANY SIGNS OF TAMPERING.
    •
    store between 20° to 25°C (68° to 77°F).
  • Inactive ingredients

    aspartame, citric acid anhydrous, colloidal silicon dioxide, flavor, magnesium stearate, mannitol, microcrystalline cellulose, sodium starch glycolate, stearic acid

  • Questions?

    call toll-free Monday to Friday 8:30 am to 5:00 pm EST at 1-800-406-7984.

    Keep the carton. It contains important information. See end panel for expiration date.

  • SPL UNCLASSIFIED SECTION

    DISTRIBUTED BY:
    RITE AID
    30 HUNTER LANE,
    CAMP HILL, PA 17011

  • PRINCIPAL DISPLAY PANEL - 30 Tablet Blister Pack Carton

    Principal Display Panel - 30 Tablet Blister Pack Carton
  • INGREDIENTS AND APPEARANCE
    DYE-FREE CHILDRENS LORATADINE 
    loratadine tablet, chewable
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:11822-9999
    Route of AdministrationOral
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    Loratadine (UNII: 7AJO3BO7QN) (Loratadine - UNII:7AJO3BO7QN) Loratadine5 mg
    Inactive Ingredients
    Ingredient NameStrength
    aspartame (UNII: Z0H242BBR1)  
    anhydrous citric acid (UNII: XF417D3PSL)  
    silicon dioxide (UNII: ETJ7Z6XBU4)  
    magnesium stearate (UNII: 70097M6I30)  
    mannitol (UNII: 3OWL53L36A)  
    microcrystalline cellulose (UNII: OP1R32D61U)  
    sodium starch glycolate type a potato (UNII: 5856J3G2A2)  
    stearic acid (UNII: 4ELV7Z65AP)  
    Product Characteristics
    ColorWHITE (white to off-white) Scoreno score
    ShapeROUND (beveled edge) Size10mm
    FlavorBUBBLE GUMImprint Code 112
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:11822-9999-33 in 1 CARTON04/01/2022
    110 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21008804/01/2022
    Labeler - RITE AID (014578892)
    Establishment
    NameAddressID/FEIBusiness Operations
    Ohm Laboratories184769029MANUFACTURE(11822-9999)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!